Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A HELLMAN

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Acta Haematologica Polonica|July 1, 1981
[Treatment of acute leukemias in adults. IV. Treatment results on 375 patients at 9 hematology centers]D Apel, M Bielawiec, A Bodzenta, et al.
Iscience|July 1, 2026
<i>In vitro</i> recapitulation of intramuscular mRNA vaccination with naive and recall antigens using a human lymphoid follicle chip platformYunhao Zhai, Min Wen Ku, Ka Yang, et al.
Nature Biomedical Engineering|March 12, 2026
DNA origami vaccine nanoparticles improve humoral and cellular immune responses to infectious diseasesYang C Zeng, Olivia J Young, Qiancheng Xiong, et al.
The Lancet. Infectious Diseases|September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trialFlonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Acta Haematologica Polonica|July 1, 1981
[Treatment of acute leukemias in adults. IV. Treatment results on 375 patients at 9 hematology centers]D Apel, M Bielawiec, A Bodzenta, et al.
Iscience|July 1, 2026
<i>In vitro</i> recapitulation of intramuscular mRNA vaccination with naive and recall antigens using a human lymphoid follicle chip platformYunhao Zhai, Min Wen Ku, Ka Yang, et al.
Nature Biomedical Engineering|March 12, 2026
DNA origami vaccine nanoparticles improve humoral and cellular immune responses to infectious diseasesYang C Zeng, Olivia J Young, Qiancheng Xiong, et al.
The Lancet. Infectious Diseases|September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trialFlonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
Pageof 8